Chronic kidney disease stages 1-3 screening, monitoring, and treatment
In individuals with hyperlipidemia and impaired estimated glomerular filtration rate (eGFR) or creatinine clearance, HMG CoA-reductase inhibitors (statins) reduced risk of mortality (RR 0.80, 95 percent CI, 0.68 to 0.95), myocardial infarction (MI), and stroke compared with placebo. However, limited...
Main Author: | |
---|---|
Corporate Authors: | , , |
Format: | eBook |
Language: | English |
Published: |
Rockville, MD
Agency for Healthcare Research and Quality
[2012], 2012
|
Series: | Comparative effectiveness reviews
|
Subjects: | |
Online Access: | |
Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Table of Contents:
- Includes bibliographical references